EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.

Autor: Chan, Ann M.1,2 (AUTHOR) vmah@ucla.edu, Aguirre, Brian1 (AUTHOR), Liu, Lucia1 (AUTHOR), Mah, Vei1 (AUTHOR), Balko, Justin M.3 (AUTHOR), Tsui, Jessica1 (AUTHOR), Wadehra, Navin P.1 (AUTHOR), Moatamed, Neda A.1 (AUTHOR), Khoshchehreh, Mahdi1 (AUTHOR), Dillard, Christen M.1 (AUTHOR), Kiyohara, Meagan1 (AUTHOR), Elshimali, Yahya4 (AUTHOR), Chang, Helena R.5 (AUTHOR), Marquez-Garban, Diana6,7 (AUTHOR), Hamilton, Nalo6,8 (AUTHOR), Pietras, Richard J.4,6,7 (AUTHOR), Gordon, Lynn K.2 (AUTHOR), Wadehra, Madhuri1,4,6 (AUTHOR) mwadehra@mednet.ucla.edu
Zdroj: Cancers. Apr2024, Vol. 16 Issue 8, p1481. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje